DDL 2022

December 7-9, 2022 | Edinburgh, Scotland

Proveris will sponsor this year’s Drug Delivery to The Lungs (DDL) conference which will be held December 7-9. Attendees to our exhibit will be able to explore new tools for spray characterization, studies for predictive in vitro / in vivo correlation, and precision automated actuation technology for through-life testing.

If you would like to learn more and schedule a meeting with us,
email us at contactus@proveris.com.

Drug Delivery to the Lungs (DDL) is an annual conference covering all aspects of respiratory drug delivery. It attracts a wide variety of attendees, including scientists, academics, clinicians, regulators and industry experts. It offers a venue for lectures, posters and exhibitions.

IDDS 2022

October 27-29 | Suzhou China

Proveris is a platinum sponsor of the 9th Innovative Drug Delivery Solution Summit (IDDS 2022) which will be held in-person from October 27-29 in Suzhou, China.

Proveris Scientific’s partner, Ruty Li of Quantaflux, will attend IDDS. He will be at the Proveris table in the exhibit area and will give a scientific presentation on behalf of Proveris. The presentation will cover analytical instrumentation and testing strategies for pressurized meter dose inhalers (pMDI’s), soft mist inhalers (SMI’s) and unit-dose nasal sprays.

If you would like to learn more and schedule a meeting with him, email us
at contactus@proveris.com.

The 9th Innovative Drug Delivery Solution Summit (IDDS·2022) which cover three special sessions, including regulatory trends and technologies for complex preparations, active packaging technology empowers pharma-cos and innovative packaging for consumer health goods, will be held online and offline during Oct and Nov. The session of regulatory trends and technologies for complex preparations will take place in Suzhou will be open to the biopharmaceutical enterprises and industry peers free of charge. Regulatory trends and technologies for high-end pharmaceutical preparations session of IDDS·2022 will invite regulatory, clinical, pharmaceutical, market experts, and industrial leading players, involve four parallel sessions: regulations and market trends, nasal to brain drug delivery, inhalation formulations and sterile formulations.

3rd Annual Inhalation & Respiratory Drug Products

September 8-9 | Proveris is a sponsor of the 3rd Annual Inhalation and Respiratory Drug Delivery Conference which, which will be held in-person from September 8-9.

Proveris Sales Director, Dr. Deborah Jones, will give a keynote speaker presentation exploring the evidence generic drug developers need to support ANDA approval for their pressurized metered dose inhaler or soft mist inhaler drug product without a clinical trial. It will focus on the in vitro spray characterization approaches; Plume Front Velocity, Spray Duration and Evaporation Fraction/Rate. It will provide data highlighting how these measurements can provide key insights that will accelerate the development process with the goal of getting products to market most efficiently.   

The 3rd Annual Inhalation and Respiratory Drug Delivery Conference is modeled for senior manager representatives, experts and main decision makers who are interested to be acquainted with the latest approaches and inventions of the respiratory drug products delivery field. It will cover the latest innovations and trends in inhalation and respiratory market, formulation & delivery of inhaled therapies, the new challenges and approaches of the inhaler models and technologies. The agenda will include content on global regulatory CMC requirements, key studies on the latest trends in inhalation devices and personalized treatments with large and small molecules for different respiratory diseases. Presentations will be focused on the topics, such as: cell therapy, inhaled vaccines and the future potential for high-dose applicants and available liquid inhalation devices. 

Learn more and register visit HERE.

RDD 2022

May 1-5, 2022 | Florida, USA

Proveris is an exhibitor and workshop presenter at this year’s Respiratory Drug Delivery, RDD 2022, which will be held in-person from May 1-5 and as a virtual conference from April 25-June 30.

Our in-person workshop scheduled for Tuesday, May 3, will last 60 minutes, and will repeated three times during the day to ensure conference delegates have the greatest opportunity to attend. Workshop presenters are Lynn Jordan, Senior Applications Manager, and Ian Flaherty, Senior Product Manager.

The workshop entitled, ‘Automated pMDI Handling for Dose Content Uniformity Testing and Aerodynamic Particle Size Distribution,’ will cover a new platform from Proveris Scientific to automate the pMDI shaking, priming, dose collection, and fire down for Dose Content Uniformity (DCU) and Aerodynamic Particle Size Distribution (APSD). Currently DCU and APSD are primarily manual processes, subject to the variability. The workshop will review testing requirements and compare the results of the manual versus automated process using the Proveris Kinaero CxTM Automated pMDI Collection System. Comparison data from both processes will be reviewed for several pMDI products, highlighting the improved performance that can be achieved by holding the testing variables consistent with the automated method. In addition, the discussion will cover the parameters available for automated mixing, an integral part of any suspension based pMDI. The workshop will conclude with a product demonstration for DCU sample preparation using the Kinaero Cx pMDI Collection System.

The exhibition session runs from 11:30 AM–2:20 PM and to 5:00 PM-7:00 PM on Monday, May 2 and on Tuesday, May 3. The Proveris team attending the conference are Ben Okorodudu, Senior Vice President of Sales, Lee Dalton, Sales Director for the Americas, Lynn Jordan, Senior Applications Manager, and Ian Flaherty, Senior Product Manager. Visit with them at the Proveris table. Schedule a private meeting or product demonstration of our new Kinaero Cx pMDI Collection System.

If you would like to learn more and schedule a meeting or product demo with us, email us at contactus@proveris.com.

Respiratory Drug Delivery, RDD®, is an international conference for researchers, regulators, business professionals and suppliers active in pulmonary and nasal drug delivery. It provides a venue for expert speakers to cover topics including new therapeutic opportunities, drug delivery technologies, regulatory science, and novel in vitro, in vivo and clinical testing methods.